Other brain-specific biomarkers used following stroke include neuron-specific enolase (NSE) (21), tau (22, 23), neurofilament light chain (NfL) (24, 25), glial fibrillary acidic protein (GFAP) (26–28), and ubiquitin C-terminal hydrolase L1 (UCH-L1) (27, 28). This evidence concerns the gene MAPT and Stroke.